Glaser N S, Jones K L
Department of Pediatrics, University of California (UC), Davis, School of Medicine, Sacramento 95817, USA.
West J Med. 1998 Jan;168(1):11-6.
To define the clinical and metabolic characteristics of children with non-insulin-dependent diabetes mellitus (NIDDM), we reviewed the medical records of 18 children and adolescents who met either or both of the following criteria for the diagnosis of the disease: evidence of continued endogenous secretion of insulin beyond that expected in insulin-dependent diabetes mellitus and satisfactory glycemic control with diet alone or in combination with an oral hypoglycemic agent more than 2 years from the time of diagnosis. Patients who met these criteria but had islet cell antibodies or insulin autoantibodies were eliminated from the study group. Patients with NIDDM constituted 8% of all patients with diabetes seen in our pediatric clinics and 19% of diabetic patients of Central or South American ancestry. Of the 18 patients, 12 (67%) were Mexican American. The mean age of onset was 12.8 years (range, 5 to 17). Obesity (n = 9) and acanthosis nigricans (n = 12) were common findings. Ketonuria was present at diagnosis in 5 (33%) of 15 patients and acidosis in 2 of 14 (14%). Challenge with a nutritional supplement (Sustacal, Mead Johnson Nutritionals) (n = 10) showed a mean fasting serum C-peptide concentration of 1.19 nmol per liter (3.6 ng per ml). A family history of NIDDM was present in 13 (87%) of 15 patients, with 7 (47%) having 3 or more generations affected. Children with NIDDM are an important subset of those with diabetes, and this disease should be suspected in diabetic children presenting without ketoacidosis and with acanthosis nigricans, obesity, and a strong family history, particularly among those of Mexican-American ethnicity. Children with these characteristics should undergo testing of endogenous insulin secretion for appropriate therapeutic intervention.
为明确非胰岛素依赖型糖尿病(NIDDM)患儿的临床和代谢特征,我们回顾了18例儿童和青少年的病历,这些患儿符合以下一项或两项该疾病诊断标准:有证据表明胰岛素持续内源性分泌超过胰岛素依赖型糖尿病预期水平,且自诊断起单用饮食或联合口服降糖药血糖控制良好达2年以上。符合这些标准但有胰岛细胞抗体或胰岛素自身抗体的患者被排除在研究组之外。NIDDM患者占我们儿科门诊所见所有糖尿病患者的8%,占中南美裔糖尿病患者的19%。18例患者中,12例(67%)为墨西哥裔美国人。平均发病年龄为12.8岁(范围5至17岁)。肥胖(9例)和黑棘皮症(12例)是常见表现。15例患者中有5例(33%)诊断时出现酮尿,14例中有2例(14%)出现酸中毒。对10例患者进行营养补充剂(苏达可,美赞臣营养品公司)激发试验,结果显示空腹血清C肽浓度平均为1.19 nmol/L(3.6 ng/ml)。15例患者中有13例(87%)有NIDDM家族史,其中7例(47%)有三代或更多代人患病。NIDDM患儿是糖尿病患儿中的一个重要亚组,对于无酮症酸中毒、有黑棘皮症、肥胖且家族史强烈的糖尿病患儿,尤其是墨西哥裔美国人,应怀疑患有此病。具有这些特征的患儿应进行内源性胰岛素分泌检测,以便进行适当的治疗干预。